CAN ONABOTULINUMTOXINA IMPROVE SYMPTOMS AND QUALITY OF LIFE IN ALL PATIENTS WITH OVERACTIVE BLADDER, REGARDLESS OF DISEASE DURATION OR BODY MASS INDEX?

被引：0
|
作者：
Chermansky, C. [1 ]
Rechberger, T. [2 ]
Miles-Thomas, J. [3 ]
Hale, D. [4 ]
Cardozo, L. [5 ]
Orejudos, A. [6 ]
Patel, A. [7 ]
Herschorn, S. [8 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[2] Med Univ Lublin, Lublin, Poland
[3] Urol Virginia, Virginia Beach, VA USA
[4] Urogynecol Associates Pc, Indianapolis, IN USA
[5] Kings Coll Hosp London, London, England
[6] Allergan Plc, Irvine, CA USA
[7] Allergan Plc, Marlow, Bucks, England
[8] Univ Toronto, Toronto, ON, Canada
来源：
NEUROUROLOGY AND URODYNAMICS | 2018年 / 37卷
关键词：
PLACEBO-CONTROLLED TRIAL; URINARY-INCONTINENCE; DOUBLE-BLIND;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
270
引用
收藏
页码：S219 / S220
页数：2
相关论文
共 50 条
  • [1] ONABOTULINUMTOXINA PROVIDES EARLY AND CONSISTENT IMPROVEMENTS IN OVERACTIVE BLADDER SYMPTOMS AND QUALITY OF LIFE OUTCOMES IN PATIENTS WITH OVERACTIVE BLADDER
    McCammon, Kurt
    Kohan, Alfred
    Kaminetsky, Jed
    Gousse, Angelo
    Gruenenfelder, Jennifer
    Orejudos, Amelia
    Aboushwareb, Tamer
    MacDiarmid, Scott
    JOURNAL OF UROLOGY, 2017, 197 (04): : E510 - E510
  • [2] ONABOTULINUMTOXINA SIGNIFICANTLY IMPROVES URINARY INCONTINENCE AND QUALITY OF LIFE IN OVERACTIVE BLADDER PATIENTS REGARDLESS OF INCONTINENCE SEVERITY AT BASELINE
    Ginsberg, D.
    Gruenenfelder, J.
    Moore, C.
    Kaufmann, A.
    Drake, M.
    Joshi, M.
    Magyar, A.
    Herschorn, S.
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S109 - S110
  • [3] OnabotulinumtoxinA reduces urinary incontinence and urgency and improves quality of life in patients with overactive bladder regardless of incontinence severity at baseline
    Drake, M.
    Ginsberg, D.
    Gruenenfelder, J.
    Moore, C.
    Kaufmann, A.
    James, C.
    Magyar, A.
    Herschorn, S.
    BJU INTERNATIONAL, 2015, 115 : 40 - 40
  • [4] ONABOTULINUMTOXINA REDUCES NOCTURNAL VOIDS AND IMPROVES QUALITY OF LIFE IN OVERACTIVE BLADDER PATIENTS WITH NOCTURIA
    Dmochowski, R.
    Ginsberg, D.
    Parsons, M.
    Robinson, D.
    Magyar, A.
    Nicandro, J.
    Drake, M.
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S107 - S107
  • [5] OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial
    Chapple, Christopher
    Sievert, Karl-Dietrich
    MacDiarmid, Scott
    Khullar, Vik
    Radziszewski, Piotr
    Nardo, Christopher
    Thompson, Catherine
    Zhou, Jihao
    Haag-Molkenteller, Cornelia
    EUROPEAN UROLOGY, 2013, 64 (02) : 249 - 256
  • [6] THE OVERACTIVE BLADDER SYNDROME (OAB) AND OBESITY: EVIDENCE OF ANTIMUSCARINIC EFFICACY REGARDLESS OF BODY MASS INDEX AT BASELINE
    Chancellor, Michael B.
    Vasavada, Sandip
    JOURNAL OF UROLOGY, 2009, 181 (04): : 676 - 676
  • [7] THE OVERACTIVE BLADDER SYNDROME (OAB) AND OBESITY: EVIDENCE OF ANTIMUSCARINIC EFFICACY REGARDLESS OF BODY MASS INDEX AT BASELINE
    Chancellor, Michael
    Oefelein, Michael
    Vasavada, Sandip
    NEUROUROLOGY AND URODYNAMICS, 2010, 29 (02) : 295 - 295
  • [8] THE EFFECT OF GENDER AND BODY MASS INDEX ON WEIGHT LOSS COUNSELING FOR OVERACTIVE BLADDER SYMPTOMS
    Quinn, Andrea
    Clark, Jessica
    Mann, Erica
    Murphy, Alana
    NEUROUROLOGY AND URODYNAMICS, 2021, 40 : S122 - S123
  • [9] Improved quality of life in patients with overactive bladder symptoms treated with solifenacin
    Kelleher, CJ
    Cardozo, L
    Chapple, CR
    Haab, F
    Ridder, AM
    BJU INTERNATIONAL, 2005, 95 (01) : 81 - 85
  • [10] ONABOTULINUMTOXINA IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH OVERACTIVE BLADDER WITH URINARY INCONTINENCE
    Sand, P. K.
    Khalaf, K. M.
    Yan, X.
    Globe, D.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2012, 23 : S191 - S192
12345